Latest Breaking News On - Pulmonary hypertension at janssen research development - Page 1 : comparemela.com

RARITAN, NJ,May 30, 2023 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a New Drug Application to the U.S. Food and Drug Administration . | May 30, 2023

Shelly orlacchioTina kittWorld health organization groupJanssen research developmentCompanies of johnsonEuropean society of cardiology respiratoryDrug administrationJanssen pharmaceutical companies of johnsonNone of the janssen pharmaceutical companiesExchange commissionPulmonary hypertension at janssen research developmentJanssen pharmaceutical companiesNew drug applicationWorld health organizationGlobal therapeutic area headPulmonary hypertension